Abstract: The present invention relates to a formulation comprising organic materials for the production of organic electronic devices having a low failure rate.
Type:
Grant
Filed:
February 9, 2015
Date of Patent:
August 4, 2020
Assignee:
Merck Patent GmbH
Inventors:
Amir Hossain Parham, Philipp Stoessel, Christof Pflumm, Anja Jatsch, Joachim Kaiser, Anna Hayer
Abstract: The present invention relates to specific ?-hydroxyketones of the formula (I) for use in the prevention and/or treatment of photodermatoses and to the use of specific ?-hydroxyketones of the formula (I) as active ingredient in typical compositions for the prevention and/or non-therapeutic treatment of photodermatoses, in particular of polymorphic light eruption.
Abstract: The present invention relates to a process for the production of hollow plastic articles in a rotational molding process as well as to hollow plastic articles made by such a process, in particular to a process for the production of hollow plastic articles which exhibit a colored surface exhibiting striking pearlescent or metallic effects.
Abstract: The present invention relates to a solid pharmaceutical preparation of 3-Fluoro-4-[7-methoxy-3-methyl-8-(1-methyl-1H-pyrazol-4-yl)-2-oxo-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl]-benzonitrile, a method of making same, and medical uses thereof.
Type:
Application
Filed:
August 8, 2018
Publication date:
July 30, 2020
Applicant:
Merck Patent GmbH
Inventors:
Simon GEISSLER, Stefan SCHILLER, Meike HARMS, Holger KUBAS, Markus WEIGANDT, Michael LANGE
Abstract: The invention relates to phenanthrene compounds comprising one or more arylamino groups. Said compounds can be used in electronic devices, in particular OLED's.
Abstract: The present invention relates to materials for organic electroluminescent devices, in particular carbazolyl compounds substituted by electron-deficient heteroaryl groups, for use as triplet matrix materials in organic electroluminescent devices, for example the compounds of formula (1). The invention further relates to a process for preparing the compounds of the invention and to electronic devices comprising these.
Abstract: The invention relates to dielectrically positive liquid crystalline media comprising a compound of formula I wherein the parameters have the meaning given in claim 1 and to liquid crystal displays comprising these media, especially to active matrix displays and in particular to TN and IPS mode displays.
Type:
Grant
Filed:
July 28, 2016
Date of Patent:
July 28, 2020
Assignee:
MERCK PATENT GMBH
Inventors:
Harald Hirschmann, Martina Windhorst, Christian Hock, Andreas Pohle, Axel Jansen
Abstract: The present application relates to mixtures which have liquid-crystalline properties. The application furthermore relates to the use of the mixtures in devices which regulate the transmission of light through an area element.
Type:
Grant
Filed:
December 12, 2016
Date of Patent:
July 28, 2020
Assignee:
MERCK PATENT GMBH
Inventors:
Michael Junge, Ursula Patwal, Peer Kirsch
Abstract: Metal complexes containing substituted allyl ligands and methods of using such metal complexes to prepare metal-containing films are provided.
Type:
Grant
Filed:
August 31, 2017
Date of Patent:
July 28, 2020
Assignee:
MERCK PATENT GMBH
Inventors:
Bin Xi, Joby Eldo, Charles Dezelah, Ravi Kanjolia, Guo Liu
Abstract: The invention relates to compounds of the formula I, in which R, A, Z, m, L1, L2, L3 and X have the meanings indicated in Claim 1, to a process for the preparation thereof, and to liquid-crystalline media comprising at least one compound of the formula I and to electro-optical displays containing a liquid-crystalline medium of this type.
Type:
Grant
Filed:
November 24, 2016
Date of Patent:
July 28, 2020
Assignee:
MERCK PATENT GMBH
Inventors:
Christian Jasper, Susann Gunst, Helmut Haensel, Brigitte Schuler
Abstract: The present invention relates to novel compounds, particularly to hydrophilic compounds, comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices. The present application also relates to ophthalmic devices comprising such compounds.
Type:
Grant
Filed:
August 3, 2016
Date of Patent:
July 28, 2020
Assignee:
Merck Patent GmbH
Inventors:
Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
Abstract: The present invention relates to alumina flakes having a defined thickness and particle size distribution and to their use in varnishes, paints, automotive coatings, printing inks, masterbatches, plastics and cosmetic formulations and as substrate for effect pigments.
Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
Type:
Application
Filed:
February 14, 2018
Publication date:
July 23, 2020
Applicant:
MERCK PATENT GMBH
Inventors:
Lars DOBELMANN-MARA, Stefan RIEDMUELLER, Martin SCHRAUB
Abstract: The present invention relates to alumina flakes having a defined thickness and particle size distribution and to their use in varnishes, paints, automotive coatings, printing inks, masterbatches, plastics and cosmetic formulations and as substrate for effect pigments.
Abstract: An auto injector having sequential control of needle insertion and dose injection is disclosed. A syringe with a needle is movably positioned in a housing between a first position in which the needle is accommodated inside the housing and a second position in which the needle protrudes outside the housing. A plunger rod tube has at least one locking member configured to normally lock a plunger rod to the plunger rod tube. A syringe driver applies a force to the syringe to move the syringe together with plunger rod tube, plunger rod and plunger rod driver from the first position to the second position. In the second position, the locking member is unlocked and releases the plunger rod to thereby activate the plunger rod driver to advance the plunger rod in the syringe for delivering of at least one dose of medicament.
Type:
Grant
Filed:
August 18, 2017
Date of Patent:
July 21, 2020
Assignee:
MERCK PATENT GMBH
Inventors:
Soeren Bechmann, Flemming Madsen, Esben W. Johansen
Abstract: The present invention provides methods of treating MS using pyrimidine and pyridine compounds which are inhibitors of Bruton's tyrosine kinase (BTK).
Abstract: A sanitation assembly (1) comprising a first chamber (2) with a first volume (2a) for receiving a first fluid, and a second chamber (3) with a second volume (3a) for receiving a second fluid, wherein the first volume (2a) communicates with an outlet (6) of the assembly (1) via a first valve mechanism (4) configured to allow discharge of the fluid from the first volume (2a) to the outlet (6) at a predefined first opening pressure, wherein the second volume (3a) communicates with the outlet (6) of the assembly (1) via a second valve mechanism (5) configured to allow discharge of the fluid from the second volume (3a) to the outlet (6) at a predefined second opening pressure, and wherein the predefined second opening pressure of the second valve mechanism (5) is higher than the predefined first opening pressure of the first valve mechanism (4).